142 related articles for article (PubMed ID: 30516685)
1. Juvenile Nasal Angiofibroma on 68Ga-PSMA PET/CT: Opening New Frontiers.
Sakthivel P; Prashanth A; Thakar A; Kumar R; Kumar R
Clin Nucl Med; 2019 Feb; 44(2):e118-e119. PubMed ID: 30516685
[TBL] [Abstract][Full Text] [Related]
2. Prostate-Specific Membrane Antigen Expression in Primary Juvenile Nasal Angiofibroma-A Pilot Study.
Sakthivel P; Thakar A; Prashanth A; Bhalla AS; Kakkar A; Sikka K; Singh CA; Kumar R; Sharma SC; Kumar R
Clin Nucl Med; 2020 Mar; 45(3):195-199. PubMed ID: 31977481
[TBL] [Abstract][Full Text] [Related]
3. Clinical Utility of 68Ga-Prostate-Specific Membrane Antigen PET/CT Scan on Postoperative Assessment of Juvenile Nasal Angiofibroma.
Thakar A; Sakthivel P; Prashanth A; Kumar R; Sharma SC; Kumar R
Clin Nucl Med; 2020 Feb; 45(2):e83-e84. PubMed ID: 31348086
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Prostate-Specific Membrane Antigen PET/CT and Contrast-Enhanced Magnetic Resonance Imaging in Follow-up Assessment of Juvenile Nasal Angiofibroma-A Novel Pilot Study.
Thakar A; Sakthivel P; Arunraj ST; Bhalla AS; Kakkar A; Kumar R; Kumar R
Clin Nucl Med; 2020 Dec; 45(12):e498-e504. PubMed ID: 33065615
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-Prostate-Specific Membrane Antigen PET/CT in Sinonasal Glomangiopericytoma-Exploring Theranostic Avenues!
Sakthivel P; Kumar A; Arunraj ST; Thakur K; Jaiswal AS; Singh CA; Kumar R
Clin Nucl Med; 2021 Apr; 46(4):340-341. PubMed ID: 33323738
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 68Ga-PSMA PET/CT and Contrast-Enhanced MRI on Residual Disease Assessment of Juvenile Nasal Angiofibroma.
Thakar A; Sakthivel P; Prashanth A; Bhalla AS; Sharma SC; Kumar R
Clin Nucl Med; 2020 Apr; 45(4):308-309. PubMed ID: 32049728
[TBL] [Abstract][Full Text] [Related]
7. Advantage of 68Ga-PSMA PET/CT on Postradiotherapy Response Assessment of Juvenile Nasal Angiofibroma.
Sakthivel P; Thakar A; Thankarajan Arunraj S; Bhalla AS; Kumar R
Clin Nucl Med; 2021 Feb; 46(2):e123-e124. PubMed ID: 33156054
[TBL] [Abstract][Full Text] [Related]
8. Fusion 68Ga-DOTANOC PET/MRI in Primary Juvenile Nasal Angiofibroma.
Sakthivel P; Thakar A; Arunraj ST; Bhalla AS; Prashanth A; Kumar R
Clin Nucl Med; 2021 Jul; 46(7):e389-e390. PubMed ID: 33630795
[TBL] [Abstract][Full Text] [Related]
9. Juvenile Nasal Angiofibroma on
Sakthivel P; Thakar A; Prashanth A; Kumar R; Sharma SC; Kumar R
Indian J Nucl Med; 2020; 35(2):176-177. PubMed ID: 32351279
[TBL] [Abstract][Full Text] [Related]
10. Negative 68Ga-Prostate-Specific Membrane Antigen PET/CT Scan on a Recurrent Juvenile Nasopharyngeal Angiofibroma.
Chandran A; Verma H; Bhalla AS; Kumar R; Kakkar A
Clin Nucl Med; 2022 Mar; 47(3):e268-e270. PubMed ID: 35020647
[TBL] [Abstract][Full Text] [Related]
11. Validation of Postoperative Angiofibroma Radionuclide Imaging Study (PARIS) Protocol Using PSMA PET/CT-A Proof of Concept Study.
Thakar A; Sakthivel P; Thankarajan Arunraj S; Bhalla AS; Prashanth A; Kumar R; Sharma SC; Kumar R
Clin Nucl Med; 2021 May; 46(5):e242-e249. PubMed ID: 33630789
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of Ga68 DOTANOC PET/CT imaging in juvenile nasal angiofibroma and the PARIS protocol: a preliminary report.
Thakar A; Sakthivel P; Arunraj ST; Bhalla AS; Prashanth A; Kumar R; Sharma SC; Kumar R
Nucl Med Commun; 2021 May; 42(5):517-522. PubMed ID: 33481507
[TBL] [Abstract][Full Text] [Related]
13.
Sakthivel P; Kumar R; Arunraj ST; Bhalla AS; Prashanth A; Kumar R; Sharma SC; Thakar A
Laryngoscope; 2021 Jul; 131(7):1509-1515. PubMed ID: 33355921
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Fusion 68Ga-Prostate-Specific Membrane Antigen PET/MRI on Postoperative Surveillance of Juvenile Nasal Angiofibroma.
Sakthivel P; Thakar A; Arunraj ST; Bhalla AS; Kumar R
Clin Nucl Med; 2020 Jul; 45(7):e325-e326. PubMed ID: 32404701
[TBL] [Abstract][Full Text] [Related]
16. 68Ga-Labeled PSMA Uptake in Nonprostatic Malignancies: Has the Time Come to Remove "PS" From PSMA?
Malik D; Kumar R; Mittal BR; Singh H; Bhattacharya A; Singh SK
Clin Nucl Med; 2018 Jul; 43(7):529-532. PubMed ID: 29688950
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of
Afshar-Oromieh A; Holland-Letz T; Giesel FL; Kratochwil C; Mier W; Haufe S; Debus N; Eder M; Eisenhut M; Schäfer M; Neels O; Hohenfellner M; Kopka K; Kauczor HU; Debus J; Haberkorn U
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1258-1268. PubMed ID: 28497198
[TBL] [Abstract][Full Text] [Related]
18. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
[TBL] [Abstract][Full Text] [Related]
19. In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography?
Kulkarni SC; Sundaram PS; Padma S
Nucl Med Commun; 2020 Feb; 41(2):139-146. PubMed ID: 31714366
[TBL] [Abstract][Full Text] [Related]
20. Pterygoid Base Pneumatization Simulating Residual Disease-A Pitfall of Structural Imaging in Juvenile Nasal Angiofibroma.
Sakthivel P; Thakar A; Verma H; Bhalla AS; Arunraj ST; Kumar R
Clin Nucl Med; 2021 Oct; 46(10):e496-e497. PubMed ID: 33826578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
